Healthcare investors are not a monolith—this list spans digital health VCs who move at software speed, medtech specialists who expect 510(k) or CE mark timelines baked into your plan, and life sciences funds comfortable with multi-year clinical development. Before you pitch, figure out which bucket your company falls into and filter accordingly. A digital health fund backing SaaS tools for provider workflows will tune out the moment you mention a three-year FDA pathway; a biotech-focused firm will wonder why you're not talking about IP protection and clinical endpoints. The mismatch wastes everyone's time. Also know that many healthcare VCs have operating partners or venture partners with deep clinical or regulatory backgrounds—these aren't just advisors, they often drive deal conviction internally. If you can get a warm intro to one of them, you're effectively pitching the firm twice.

​

Expect diligence to take longer than in pure software. Healthcare investors will want to understand your regulatory strategy, reimbursement pathway, and how you plan to navigate the notoriously slow sales cycles with health systems or payers. Come prepared with a clear answer on who pays (patient, provider, employer, insurer) and why that buyer has budget authority and urgency. If you're pre-revenue, show letters of intent, pilot commitments, or at minimum, documented conversations with target customers that prove demand isn't hypothetical. One more thing: healthcare VCs talk to each other constantly, especially within subspecialties. A sloppy process or inflated metrics will circulate faster than you'd expect. Run a tight, honest raise—your reputation in this relatively small investor community compounds over time.